Kazia Therapeutics (KZIA) Times Interest Earned (2009 - 2011)

Kazia Therapeutics (KZIA) posted Times Interest Earned of $52.22 for Q4 2011, down 84.03% on a QoQ basis from $327.06 in Q4 2010, and down 84.03% year-over-year from $327.06 in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of Times Interest Earned data on file, last reported at $52.22 in Q4 2011.

  • In Q4 2011, Times Interest Earned fell 84.03% year-over-year to $52.22; the TTM figure through Dec 2011 stood at $115.58 (down 79.65% YoY), while the FY2011 annual figure was -$860.5, up 33.37% from the prior year.
  • Times Interest Earned eased to $52.22 in Q4 2011, from $327.06 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $582.36 in Q4 2009 and bottomed at $52.22 in Q4 2011.
  • A 3-year average of $320.55 and a median of $327.06 in 2010 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2010 — Times Interest Earned tumbled 43.84% — and 2011, when it plunged 84.03%.
  • Year by year, Times Interest Earned stood at $582.36 in 2009, then tumbled by 43.84% to $327.06 in 2010, then plunged by 84.03% to $52.22 in 2011.
  • The last three Times Interest Earned figures came in at $52.22 (Q4 2011), $327.06 (Q4 2010), and $582.36 (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 52.22
Dec 31, 2010 327.06
Dec 31, 2009 582.36